La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Citius Pharmaceuticals a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Citius Pharmaceuticals..

Citius Pharmaceuticals (NASDAQ:CTXR) Azioni, Catena delle Opzioni

CITIUS PHARMACEUTICALS INC

Citius Pharma

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

News

Pre-Market Outlook

Markets

Trading Ideas

$LUNA

CCTG

CTXR

LUNA

Oggi alcuni titoli azionari stanno attirando particolare attenzione nel pre-market a causa di annunci chiave e movimenti significativi.

Pre-market: 5 titoli da monitorare oggi, 30 dicembre 2024

Citius Pharmaceuticals, Inc. - Common Stock

Citius Pharmaceuticals Inc

Home furnishing brand The Lovesac Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOVE#NASDAQ">LOVE</a>) shares are <a href="https://www.benzinga.com/premarket">surging in premarket on Thursday</a>, after the fourth-quarter earnings.
The company reported a <a href="https://www.benzinga.com/pressreleases/25/04/g44730835/the-lovesac-company-reports-fourth-quarter-and-fiscal-2025-financial-results">fourth-quarter FY25 revenue decline </a>of 3.6% year-on-year to $241.490 million, beating the analyst consensus estimate of $233.954 million.
Gross profit decreased 2.6% Y/Y to $145.8 million, with the margin expanding 70 basis points to 60.4%. Total comparable sales declined 9.4%. Internet sales dropped 9.7% in the quarter.
Total operating expenses fell 10.1% Y/Y to $98.2 million. The operating income increased 17.8% to $47.6 million and the operating margin expanded 360 basis points to 19.7%.
Also Read: <a href="https://www.benzinga.com/news/25/04/44698868/tariffs-recession-fears-could-derail-wayfair-rh-and-etsy-says-analyst">Tariffs, Recession Fears Could Derail Wayfair, RH And Etsy, Says Analyst</a>
Adjusted EBITDA increased 11.4% Y/Y to $53.9 million. EPS of $2.13&nbsp;<a href="https://www.benzinga.com/earnings">topped the consensus </a>of $1.87.
As of July 30, 2023, Lovesac held $54.7 million in cash and equivalents. Net cash provided by operating activities during the quarter totaled $44 million.
&#8220;After a slow start to the holiday selling season, strong execution by our teams dramatically improved conversion of customer quotes to sales throughout the remainder of the fourth quarter. This supported a mid-teens year-over-year increase in net income for the quarter and helped close out another year of market share gains for full year Fiscal 2025,&#8221; said CEO Shawn Nelson.
Lovesac appointed Heidi Cooley as <a href="https://www.benzinga.com/pressreleases/25/04/g44730896/the-lovesac-company-appoints-heidi-cooley-as-chief-brand-and-marketing-officer">Chief Brand and Marketing Officer</a>, effective April 23, 2025. 
Outlook: For the first quarter Lovesac sees EPS of $(0.66) &#8211; $(0.85) versus the Street view of $(0.77) and sales of $136 million &#8211; $142 million against the estimate of $138.60 million.
The company expects FY26 EPS of $0.80 &#8211; $1.36 versus the estimate of $1.10 and sales of $700 million &#8211; $750 million versus the estimate of $713.05 million.
Price Action: LOVE shares traded higher by 16.38% at $18.54 in premarket at last check Thursday.
Read Next: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44703031/this-beverage-maker-tobacco-company-and-packaged-food-giant-outshine-in-a-recession">This Beverage Maker, Tobacco Company And Packaged Food Giant Outshine In A Recession</a>
Photo: Shutterstock

General

LOVE

Why Is Home Furnishing Brand Lovesac's Stock Surging Today?

BRTX

BioRestorative Therapies Confirms It Faces No Material Impact From Reciprocal Tariffs

NextNRG, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXXT#NASDAQ">NXXT</a>), a pioneer in AI-driven energy innovation—transforming how energy is produced, managed, and delivered through its advanced Utility Operating System, smart microgrid technology, wireless EV charging, and on-demand mobile fuel delivery solutions— today announced preliminary unaudited revenue and volume results for March 2025 and the first quarter of 2025. The company delivered its third consecutive record month, with March revenue increasing 161% year-over-year to approximately $6.15 million.
March 2025 Highlights
<ul>
<li>Revenue: $6,148,266 (vs. $2,354,048 in March 2024)</li>
<li>YoY Revenue Growth: 161%</li>
<li>Gallons Delivered: 1,799,955 (vs. 580,217 in March 2024)</li>
<li>YoY Gallon Growth: 210%</li>
</ul>
Q1 2025 Highlights
<ul>
<li>Revenue: $16,232,354 (vs. $6,597,119 in Q1 2024)</li>
<li>YoY Revenue Growth: 146%</li>
<li>Gallons Delivered: 4,688,045 (vs. 1,658,272 in Q1 2024)</li>
<li>YoY Gallon Growth: 183%</li>
</ul>

Earnings

Guidance

NXXT

NextNRG Reports Preliminary March 2025 Revenue Of $6,148,266 Up From $2,354,048 YoY; Q1 Revenue $16,232,354 Up From $6,597,119 YoY

United States Steel Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>) shares are facing selling pressure on Thursday after President Donald Trump suggested he doesn't want to see the company get <a href="https://www.benzinga.com/markets/commodities/25/04/44679320/us-steel-gains-16-as-trump-orders-review-of-nippon-steels-blocked-acquisition-amid-national-security-concerns" target="_blank" rel="noreferrer noopener">acquired by Nippon Steel</a>.
What To Know: In a <a href="https://www.youtube.com/watch?v=qr9AeMFXzpY" target="_blank" rel="noreferrer noopener">press conference</a> from the Oval Office after the market close on Wednesday, Trump told reporters he wants U.S. Steel to remain a U.S. company. 
"We don't want to see it go to Japan. You know, we love Japan, but U.S. Steel is a very special company," Trump said.
U.S. Steel and Nippon Steel filed lawsuits in January after the Biden administration blocked Nippon&#8217;s proposed $14.9-billion acquisition of U.S. Steel, originally announced at the end of 2023. The companies claimed &#8220;wrongful interference&#8221; with the planned takeover deal. 
The Biden administration said last year that it was <a href="https://www.benzinga.com/news/24/07/39613777/amid-opposition-from-biden-and-workers-nippon-steel-vc-returns-to-discuss-us-steel-acquisition" target="_blank" rel="noreferrer noopener">"vital"</a> that U.S. Steel remained a domestically operated American steel company. The proposed acquisition had become a major topic of discussion leading up to the presidential election in November.
U.S. Steel shares surged earlier this week after Trump ordered a <a href="https://www.benzinga.com/markets/commodities/25/04/44679320/us-steel-gains-16-as-trump-orders-review-of-nippon-steels-blocked-acquisition-amid-national-security-concerns" target="_blank" rel="noreferrer noopener">national security review</a> of the company's blocked deal with Nippon Steel. The stock reversed course following Trump&#8217;s comments late Wednesday. 
"If you go back to U.S. Steel from 90 years ago, it&#8217;s incredible. It was the number one company in the world for a long time. That's why we don't want to see it go to Japan,&#8221; Trump said. 
X Price Action: <a href="http://benzinga.com/quote/X" target="_blank" rel="noreferrer noopener">U.S. Steel shares</a> were down 11.6% at $39.91 at the time of publication Thursday morning, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Photo: <a href="https://www.shutterstock.com/g/saweangw">saweang.w</a>/Shutterstock.

Movers

US Steel Stock Is Falling Thursday: What's Going On?

JMP Securities analyst Constantine Davides maintains Addus HomeCare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADUS#NASDAQ">ADUS</a>) with a Market Outperform and maintains $150 price target.

Price Target

Analyst Ratings

ADUS

JMP Securities Maintains Market Outperform on Addus HomeCare, Maintains $150 Price Target

Red Cat Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCAT#NASDAQ">RCAT</a>) shares are moving lower Thursday after the company announced a $30 million registered direct offering <a href="https://www.benzinga.com/pressreleases/25/04/g44730836/red-cat-holdings-announces-30-million-registered-direct-offering-of-common-stock">of its common stock</a>. 
What Happened: Before the market open on Thursday, Red Cat announced it entered into securities purchase agreements with institutional investors for the purchase and sale of approximately 4.72 million shares of common stock. 
The drone technology company anticipates gross proceeds of approximately $30 million. The offering is expected to close on or about April 11. 
Red Cat said it intends to use the net proceeds from the offering for general corporate purposes. The company had $9.6 million in cash and accounts receivable as of the end of 2024. When Red Cat reported financial results last month, the company noted that it closed on an additional $6 million in financing since the reporting period ended. 
Red Cat said last quarter that it expects calendar year 2025 revenue of $80 million to $120 million, including $25 million from non-SRR Black Widow sales, $25 to $65 million in SRR-related Black Widow sales, $25 million in Edge 130 sales and $5 million in Fang FPV sales.
Check This Out: <a href="https://www.benzinga.com/government/regulations/25/04/44730455/bearish-sentiment-hits-7-week-high-mimicking-35-year-old-record-which-marked-the-bottom-of-the-october-1990-bear-market">Bearish Sentiment Hits 7-Week High, Mimicking 35-Year Old Record Which Marked The Bottom Of The October 1990 Bear Market</a>
<h3 class="wp-block-heading">How To Buy RCAT Stock</h3>
By now you're likely curious about how to participate in the market for Red Cat &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
RCAT Price Action: <a href="http://benzinga.com/quote/rcat" target="_blank" rel="noreferrer noopener">Red Cat Holdings shares</a> were down 9.39% at $6.75 at the time of publication Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
This illustration was generated using artificial intelligence via Midjourney.

Offerings

RCAT

Red Cat Holdings Stock Is Trading Lower Thursday: Here's Why

Ginkgo Bioworks and partners awarded $29 million contract by ARPA-H to develop distributed manufacturing of essential medicines using wheat germ cell-free expression systems

Contracts

Ginkgo Bioworks Works With Partners On ARPA-H Project To Stabilize Pharmaceutical Supply Chains

Topgolf Callaway Brands Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MODG#NYSE">MODG</a>) <a href="https://www.benzinga.com/pressreleases/25/04/n44729290/topgolf-callaway-brands-announces-agreement-to-sell-jack-wolfskin-to-anta-sports">agreed to divest</a> its Jack Wolfskin unit to Chinese sportswear maker ANTA Sports for $290 million in cash.
The transaction is expected to be completed in the second quarter or early third quarter of 2025.
 &#8220;This sale will allow us to increase our focus and optimize our resources on our core business. Importantly, the proceeds will further enhance our balance sheet and liquidity, reinforcing our financial flexibility ahead of our planned separation of Topgolf from our core operations,&#8221; said Topgolf CEO Chip Brewer.
Also Read: <a href="https://www.benzinga.com/news/25/04/44698868/tariffs-recession-fears-could-derail-wayfair-rh-and-etsy-says-analyst">Tariffs, Recession Fears Could Derail Wayfair, RH And Etsy, Says Analyst</a>
Last year, Topgolf&#8217;s board revealed plans to split its operations, aiming to separate the Callaway and Topgolf divisions. The company intends to separate by spinning off the Topgolf segment to its shareholders.
While Topgolf Callaway has not updated its fiscal outlook following the deal, the company<a href="https://www.benzinga.com/pressreleases/25/02/n43926091/topgolf-callaway-brands-announces-fourth-quarter-and-full-year-2024-results"> had earlier forecast Jack Wolfskin </a>to generate roughly 325 million euros ($359.64 million) in revenue for the full year 2025. 
This included an anticipated adjusted EBITDA of 12 million euros. The brand's performance is expected to remain seasonal, with an adjusted EBITDA loss of 18 million euros in the first half offset by an adjusted EBITDA of 30 million euros in the latter half.
Topgolf Callaway enlisted Goldman Sachs as its financial advisor for the deal, with Latham &amp; Watkins LLP providing legal counsel.
The company held $445 million in cash and equivalents as of Dec. 31.
J.P. Morgan analyst Matthew R. Boss reiterated a Neutral rating on the company&#8217;s shares and warned that Topgolf's same-venue sales will <a href="https://www.benzinga.com/analyst-ratings/price-target/25/02/43954172/topgolf-callaway-to-face-revenue-challenges-as-same-venue-sales-drop-by-8-analyst">face challenges over the next 12-18 months</a> as both corporate and consumer demand remain below normal levels.
Topgolf Callaway offers equipment, apparel, and entertainment through global brands like Topgolf, Callaway Golf, TravisMathew, Odyssey and OGIO.
Price Action: Topgolf shares traded higher by 1.1% at $6.41 in premarket at last check Thursday.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44703031/this-beverage-maker-tobacco-company-and-packaged-food-giant-outshine-in-a-recession">This Beverage Maker, Tobacco Company And Packaged Food Giant Outshine In A Recession</a></li>
</ul>
Image: Shutterstock

Sports

MODG

Sports Equipment Maker Topgolf Callaway To Sell Jack Wolfskin Brand For $290M

Scotiabank analyst Greg McGinniss downgrades Lineage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINE#NASDAQ">LINE</a>) from Sector Outperform to Sector Perform and lowers the price target from $74 to $56.

Downgrades

LINE

Scotiabank Downgrades Lineage to Sector Perform, Lowers Price Target to $56

Management

SMRT

SmartRent President And CEO Shane Paladin Resigns, Effective Immediately; Chairman John Dorman Named Interim CEO

– The Steering Committee brings together distinguished clinical experts in AML from leading National Comprehensive Cancer Network Centers –
Omeros Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMER#NASDAQ">OMER</a>) today announced the establishment of the Omeros Oncology Clinical Steering Committee to advance Omeros' OncotoX biologics program focused on acute myeloid leukemia (AML). AML is the most fatal form of leukemia and accounts for approximately 80 percent of acute leukemias in adults and one-third of all cancers affecting the blood/bone marrow, representing a high unmet need. Omeros' OncotoX program for AML consists of proprietary targeted, engineered molecules (about half the size of an antibody) that deliver a toxic payload within the cancer cells, thereby killing them.

Biotech

OMER

Omeros Establishes Oncology Clinical Steering Committee Of Leading AML Experts From Top Cancer Centers To Advance Its OncotoX Biologics Program Targeting High-Unmet-Need Acute Myeloid Leukemia With Proprietary Engineered Molecules Designed To Deliver Cancer-Killing Payloads

The technology sector is preparing for a period of uncertainty and volatility due to recent tariffs and the upcoming earnings season, according to Wedbush analyst Dan Ives.
What Happened: Despite hopes for stability following a pause in tariffs last year, the tech industry is facing a less certain reality. Large-scale purchases may see significant downsizing or pauses, contributing to the sector&#8217;s volatility, said Ives.
The tech analyst attributes this turbulence to recent tariffs, which have reached as high as 125% on China, significantly impacting the tech industry. While he stated that the pause on tariffs is a good sign, there is still a lot of uncertainty. &#8220;There is a framework but the reality is there is mass uncertainty.&#8221;
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Ives: Buckle up—Tech is heading into a period of major volatility" width="500" height="281" src="https://www.youtube.com/embed/zO58ikRXbAM?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
These tariffs have led to a dramatic pullback in capital expenditure (CapEx), especially on data centers. Companies such as Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>), and Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) have all felt the impact, with spending plans stalled as they navigate this new reality.
As earnings season approaches, Dan&nbsp;anticipates further turbulence and predicts&nbsp;earnings cuts of about 10%&nbsp;across internet and big tech. The&nbsp;tech world is still assessing&nbsp;the full extent of the&nbsp;damage, with&nbsp;the potential for a U.S.-China&nbsp;deal looming large.
 "​Street numbers now you are assuming across the board you will see earning cuts to about 10% across internet and big tech.," he predicted. 
The Wedbush Analyst stated that the June quarter would be very soft and investors are looking ahead to any sign of a China deal and a de-escalation. 
SEE ALSO:&nbsp;<a href="https://benzinga.com/markets/25/04/44730488/jim-cramer-reminds-investors-nobody-ever-made-a-dime-panicking-after-market-rally-amid-tariff-pause" target="_blank" rel="noreferrer noopener">Jim Cramer Reminds Investors &#8216;Nobody Ever Made A Dime Panicking&#8217; After Market Rally Amid Tariff Pause</a>
Why It Matters: The <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44721874/trumps-tariff-pause-saves-market-from-edge-of-the-cliff-dan-ives-says-biggest-wild-card-still-remains">90-day tariff pause</a>, announced by President Donald Trump, was initially seen as a relief for the stock market. However, despite the rally in markets, analysts warned of a &#8220;key obstacle&#8221; still on the table.
Ives&#8217; concerns about pauses in data center capex are relevant as reports suggest that Microsoft has recently shelved a $1 billion data center investment in Ohio.
Trump&#8217;s more lenient approach to his trade agenda led to a <a href="https://www.benzinga.com/25/04/44728207/trump-says-this-is-a-great-time-to-buy-but-portfolio-managers-give-a-reality-check-permanent-damage-has-been-done">significant rally</a> in the stock market. However, portfolio managers and analysts were not fully convinced. They believed that the escalating trade war and a worrying selloff in the U.S. government bond market had caused permanent damage.
For tech companies, the road ahead remains volatile. The combination of paused projects, tariff-driven cost increases, and cautious guidance paints a challenging picture for the industry. As Dan Ives put it, "The damage is real."
<ul>
<li>READ NEXT:&nbsp;<a href="https://benzinga.com/trading-ideas/long-ideas/25/04/44697177/marjorie-taylor-greene-buys-the-dip-congresswoman-purchases-shares-of-apple-amazon-nike-" target="_blank" rel="noreferrer noopener">Marjorie Taylor Greene Buys The Dip: Congresswoman Purchases Shares Of Apple, Amazon, Nike And More Following Tariff-Related Sell-Off</a></li>
</ul>

Tech

AAPL

AMZN

GOOG

GOOGL

MSFT

Tech Sector Entering A Period Of 'Mass Uncertainty' Amid Tariffs And Upcoming Earnings Season, Says Dan Ives: 'The Damage Is Real'

ESTA

Establishment Labs Holdings Sees Prelim. Q1 Revenue ~$41.4M Vs $40.762M Est.

No gainer in today's Pre-market session. 
<h3>Losers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>SPDR Select Sector Fund - Technology</td>
<td align="right">198.5800</td>
<td align="right">-5.28</td>
<td align="right">-2.60</td>
<td>83.4K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)</td>
<td>SPDR Select Sector Fund - Energy Select Sector</td>
<td align="right">80.3900</td>
<td align="right">-1.97</td>
<td align="right">-2.40</td>
<td>136.2K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>)</td>
<td>SPDR Select Sector Fund - Consumer Discretionary</td>
<td align="right">191.4700</td>
<td align="right">-4.07</td>
<td align="right">-2.09</td>
<td>14.7K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>)</td>
<td>The Communication Services Select Sector SPDR Fund</td>
<td align="right">91.9297</td>
<td align="right">-1.81</td>
<td align="right">-1.94</td>
<td>13.5K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLB#NYSE">XLB</a>)</td>
<td>Materials Select Sector SPDR</td>
<td align="right">79.2300</td>
<td align="right">-1.53</td>
<td align="right">-1.90</td>
<td>6.6K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>)</td>
<td>SPDR Select Sector Fund - Industrial</td>
<td align="right">124.8300</td>
<td align="right">-1.93</td>
<td align="right">-1.53</td>
<td>44.7K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>SPDR Select Sector Fund - Financial</td>
<td align="right">46.6600</td>
<td align="right">-0.57</td>
<td align="right">-1.21</td>
<td>823.1K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>)</td>
<td>Real Estate Select Sector SPDR Fund (The)</td>
<td align="right">38.7600</td>
<td align="right">-0.45</td>
<td align="right">-1.15</td>
<td>2.6K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)</td>
<td>SPDR Select Sector Fund - Utilities</td>
<td align="right">75.5500</td>
<td align="right">-0.42</td>
<td align="right">-0.56</td>
<td>9.8K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>)</td>
<td>SPDR Select Sector Fund - Health Care</td>
<td align="right">138.0100</td>
<td align="right">-0.75</td>
<td align="right">-0.55</td>
<td>35.7K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>)</td>
<td>SPDR Select Sector Fund - Consumer Staples</td>
<td align="right">79.0400</td>
<td align="right">-0.27</td>
<td align="right">-0.35</td>
<td>10.7K</td>
</tr>
</tbody>
</table>
<a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data</a> this sector movers alerts can help traders understand macro-level market trends. Traders often look for sector movers to provide high-level analysis on which sectors are over- or under-performing to make better investing decisions on exchange traded funds (ETFs) or individual tickers in those sectors. 
For more information on sector movers, <a href="https://www.benzinga.com/movers">click here</a>.

Sector ETFs

ETFs

XLRE

Select Sector SPDR-Consumer Discretionary

Leading And Lagging Sectors For April 10, 2025

Chris Dixon, managing partner at venture firm a16z crypto, says blockchain-based stablecoins are transforming the global payments landscape in the same way <a href="https://www.benzinga.com/news/25/04/44709542/investors-just-poured-3m-into-this-whatsapp-job-app-for-hispanic-immigrants-and-its-already-helping-800-find-work">WhatsApp upended costly international phone calls</a>.
What Happened: In a blog post published on Thursday, Dixon <a href="https://a16zcrypto.com/posts/article/stablecoins-payments-without-intermediaries/">outlines</a> how stablecoins are emerging as internet-native alternatives to legacy financial networks bogged down by fees, delays and multiple intermediaries.
"The internet made information free and global. So why is it still so hard — and expensive — to move money?" Dixon asks. 
He points out that a $200 international remittance still costs an average of 6.62% in fees, which he calls a regressive tax on the world's poorest workers.
Stablecoins—cryptocurrencies pegged to assets like the US dollar like USDT (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDT</a>) and USDC (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDC</a>)—offer a reset. According to Dixon, they eliminate the need for traditional clearing houses, correspondent banks and foreign exchange intermediaries.
"Just as WhatsApp disrupted costly international phone calls, blockchain payments and stablecoins are transforming global money transfers," he wrote.
The report highlights several use cases already in motion. 
SpaceX is using stablecoins for treasury operations in countries with volatile currencies, while companies like ScaleAI leverage them for fast, low-cost international payroll. 
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44731819/why-the-bitcoin-bull-market-is-back-on-at-93000-glassnode">Why The Bitcoin Bull Market Is Back On At $93,000: Glassnode</a>
Stripe, the payments processor, now supports stablecoin checkouts with fees as low as 1.5%, compared to the 3% typically charged by card networks.
Dixon says that stablecoins processed $15.6 trillion in value in 2024—equivalent to Visa's volume—demonstrating real-world adoption beyond theoretical promise. 
"Unlike the old financial stack, which evolved in silos, stablecoins are global by default. They live on blockchains: open, programmable networks that anyone can build on," he said.
He adds that regulatory clarity could accelerate stablecoin adoption. 
"Smart legislation is actually the unlock," Dixon says, pointing to ongoing efforts in Congress to clarify rules around network tokens and security classifications.
What&#8217;s Next: Dixon also sees a broader shift in how money infrastructure should be built—more like the open internet protocols that fueled decades of innovation. "We don't have to patch the old system. We can make a better one."
With market demand, developer interest, and regulatory momentum converging, Dixon argues that stablecoins are no longer an experiment—they're emerging as a foundational layer of the global financial system.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44720918/trump-tariffs-are-pressuring-bitcoin-bonds-commodities-vaneck-warns">Trump Tariffs Are Pressuring Bitcoin, Bonds, Commodities, VanEck Warns</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$USDC

$USDT

Stablecoins Are Doing For Money What WhatsApp Did For Messaging, Crypto Venture Capitalist Says

Volkswagen AG (OTC:<a class="ticker" href="https://www.benzinga.com/stock/VWAGY#OTC">VWAGY</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/VLKAF#OTC">VLKAF</a>) witnessed a robust uptick in its electric vehicle (EV) business across Europe during the first quarter of 2025 as <a href="https://www.benzinga.com/topic/auto-industry" target="_blank" rel="noreferrer noopener">demand for battery-powered cars continued to climb.</a>
Volkswagen <a target="_blank" href="https://www.volkswagen-group.com/en/press-releases/volkswagen-group-doubles-all-electric-deliveries-in-europe-19162" rel="noreferrer noopener">delivered </a>939,800 vehicles across Europe between January and March, marking a 3.7% year-over-year growth.
The gains were especially pronounced in Central and Eastern Europe, where deliveries jumped 7.9%. Western Europe followed with a 3.0% rise, while Germany, the automaker&#8217;s home turf, posted a 5.5% increase. The positive trend offset an anticipated drop in sales in China, USA Today reports.
Meanwhile, Volkswagen&#8217;s shares rose 8.2% after the U.S. paused new tariffs for 90 days, Reuters reports, bringing some relief to markets.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/04/44729384/trump-pauses-tariffs-after-yields-surge-bond-vigilantes-hit-another-homerun-experts-point-to-bond-market-panic-for-reversal" rel="noreferrer noopener">Trump Pauses Tariffs After Yields Surge: &#8216;Bond Vigilantes Hit Another Homerun,&#8217; Experts Point To Bond Market Panic For Reversal</a>
However, a 25% tariff on auto imports is still in effect, which remains a concern for<a target="_blank" href="https://www.benzinga.com/25/04/44729499/rh-rallies-after-trump-pauses-tariffs-that-triggered-40-selloff" rel="noreferrer noopener"> Volkswagen due to its heavy exposure.</a>
Marco Schubert, a member of the company&#8217;s extended executive committee for sales, stated that strong performances in both the Americas and Europe compensated for the Chinese market slump.
Recall Alert For Audi Vehicles
Separately, Volkswagen&#8217;s luxury division, Audi, has recently initiated a recall campaign for over 44,000 vehicles in the U.S., affecting models from the 2021 production year.
The recall affects models including the SQ8, A6 sedan, A7, A8, Q7, Q8, RS6 Avant, RS7, RSQ8, S6 sedan, S7, S8, A6 Allroad, and SQ7.
The issue stems from a deteriorating flex-foil cable that can trigger a software error, potentially causing the digital instrument panel to go blank, USA Today <a href="https://www.usatoday.com/story/money/cars/recalls/2025/04/09/volkswagen-recalls-2021-audi-models/83009319007/">reports</a>. This malfunction could hinder access to essential driving data such as speed, warning indicators, mileage and gear position.
Resolution Plan And Customer Impact
As of March 24, Audi had received 2,285 customer complaints. Fortunately, no accidents or injuries have been linked to the issue.
According to a <a target="_blank" href="https://www.nhtsa.gov/recalls?nhtsaId=25V201000" rel="noreferrer noopener">filing </a>with the National Highway Traffic Safety Administration, dealerships will offer software updates free of charge to fix the problem.
Notification letters are scheduled to reach affected owners beginning May 30, 2025.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44709538/shapiros-treasury-market-dysfunction-warning-hits-home-buying-more-gold-as-fed-put-may-be-on-the-table" target="_blank" rel="noreferrer noopener">Shapiro's Treasury ‘Market Dysfunction' Warning Hits Home: ‘Buying More Gold' As Fed Put May Be On The Table</a></li>
</ul>
Photo: Shutterstock

Equities

VLKAF

VWAGY

Volkswagen Sees EV Boom In Europe While Audi Battles Recall Woes Amid Tariff Turbulence

WIIM

BioGene shares are trading higher. Guggenheim reiterated a Buy rating on the stock.

AES Technology shares are trading lower. The company reported Q1 and monthly revenue results.

Guggenheim analyst Seamus Fernandez reiterates MBX Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBX#NASDAQ">MBX</a>) with a Buy and maintains $44 price target.

Reiteration

Guggenheim Reiterates Buy on MBX Biosciences, Maintains $44 Price Target

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>UBS analyst Joseph Spak downgraded the rating for BorgWarner Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWA#NYSE">BWA</a>) from Buy to Neutral and lowered the price target from $38 to $31. BorgWarner shares closed at $26.89 on Wednesday. <a href="https://www.benzinga.com/quote/bwa/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS analyst Joseph Spak downgraded General Motors Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) from Buy to Neutral and slashed the price target from $64 to $51. General Motors shares closed at $45.74 on Wednesday. <a href="https://www.benzinga.com/quote/gm/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Goldman Sachs analyst Mark Delaney downgraded the rating for Ford Motor Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) from Buy to Neutral and cut the price target from $11 to $9. Ford shares closed at $9.50 on Wednesday. <a href="https://www.benzinga.com/quote/F/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst Julien Dumoulin-Smith downgraded The AES Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AES#NYSE">AES</a>) from Buy to Hold and lowered the price target from $15 to $10. AES shares closed at $11.14 on Wednesday. <a href="https://www.benzinga.com/quote/AES/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan analyst Richard Sunderland downgraded the rating for Portland General Electric Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/POR#NYSE">POR</a>) from Overweight to Neutral and lowered the price target from $50 to $44. Portland Gen Electric shares closed at $42.28 on Wednesday.  <a href="https://www.benzinga.com/quote/POR/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying GM stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="594" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/10090642/image-68-1024x594.png" alt="" class="wp-image-865955" style="width:562px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/10090642/image-68-1024x594.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/10090642/image-68-300x174.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/10090642/image-68-768x446.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/10090642/image-68.png 1072w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44710375/top-2-materials-stocks-that-may-fall-off-a-cliff-this-quarter">Top 2 Materials Stocks That May Fall Off A Cliff This Quarter</a> </li>
</ul>
Photo via Shutterstock

This General Motors Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

Press Releases

Citius Pharmaceuticals Announces Closing of $3 Million Registered Direct Offering

Stock Split

Citius Pharmaceuticals, Inc. Announces 1-for-25 Reverse Stock Split

Citius Pharmaceuticals Reports Productive FDA Type C Meeting to Discuss Phase 3 Mino-Lok® Program and Pathway to Approval

Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update

Small Cap

Citius Oncology Engages Jefferies as Exclusive Financial Advisor to Explore Strategic Alternatives

Citius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch Planned for the First Half of 2025

Citius Pharmaceuticals Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services

Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update

Citius Pharmaceuticals Announces $2 Million Registered Direct Offering of Common Stock

CTOR

Adial Pharmaceuticals, Inc - Common Stock

Adial Pharmaceuticals

Athira Pharma

Aytu BioPharma

Biofrontera

CalciMedica

Cognition Therapeutics, Inc. - Common Stock

Cognition Therapeutics

Cingulate

Cocrystal Pharma

Citius Pharmaceuticals

Durect

Gelteq

Hoth Therapeutics

Impact BioMedical

IGC Pharma

Jupiter Neurosciences, Inc. - Common Stock

Jupiter Neurosciences

Kiora Pharmaceuticals, Inc. - Common Stock

Kiora Pharmaceuticals

Lipocine

Lyra Therapeutics

MIRA Pharmaceuticals, Inc. - Common Stock

Mira Pharmaceuticals

Purple Biotech Ltd. - American Depositary Shares

Purple Biotech

ProPhase Labs

Pulmatrix

Relmada Therapeutics, Inc. - Common Stock

Relmada Therapeutics

Talphera

Traws Pharma

TherapeuticsMD

D. Boral Capital

HC Wainwright & Co.

EF Hutton

Screenshot 2024-08-06 at 7.17.40 PM

TENK

Citius Pharmaceuticals To Receive 65 Million Shares Of TenX Keane For Merger Of Citius Oncology

Screenshot 2024-07-29 at 8.39.42 PM

From fighting cancer to treating bloodstream infections, Citius Pharmaceuticals Inc. (NASDAQ:CTXR) is busy trying to solve some of the world&#39;s ills. That&#39;s picking up steam with two of its lead products close to commercialization. 

Citius Pharmaceuticals Nears Market Breakthrough With Two Leading Products

Screenshot 2024-07-24 at 5.43.01 PM

Interview

This Pharma Company Is Preparing To Launch Its Lead Candidate

Screenshot 2024-04-17 at 5.34.28 PM

Citius Pharmaceuticals (NASDAQ: CTXR) Advances Oncology Asset, Paving Way For Spin Out Of Advanced T-cell Lymphoma Treatment

Comments

Citius Pharmaceuticals

Citius Pharmaceuticals (CTXR) Opzioni

Citius Pharmaceuticals (NASDAQ:CTXR) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO